Physician

Aria Dibiase, MD

According to 2025 Medicare claims, Aria Dibiase, MD (NPI: 1033273727) practices advanced heart failure and transplant cardiology in the San Jose-Sunnyvale-Santa Clara, CA market, with the plurality of this provider's patient population coming from Santa Clara, CA. This provider's primary affiliated billing organization is SUTTER BAY MEDICAL FOUNDATION (NPI: 1013950807; TIN: 941156581) and primary practice location at 94301-2322. Dibiase is affiliated with the Sutter Medicare Direct (ACO ID: A5279), participating under the MSSP model.

Dibiase's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 1,617 traditional Medicare patients, billed 2,318 HCPCS/CPT codes, and received $190,890 in Medicare payments. The top billing code was 93351 (Ultrasound of heart with continuous electrocardiogram (ecg) during rest, exercise and/or drug induced stress with review and report). Part D data shows 2,256 prescription claims across 246 beneficiaries totaling $1,657,911 in drug costs, led by Vyndamax (Tafamidis). Open Payments data shows 1 records totaling $129. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has changed little. Concurrently, Part D prescription costs have moved sharply higher in recent years, from $92,588 to $1,657,911. For DME billing, this provider has fewer than 5 years of reported data, so a reliable trend cannot be assigned.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Year	Patients	Clm Lines	Payment
2015	1,660	2,325	$179,621
2016	1,592	2,282	$180,818
2017	1,692	2,277	$200,740
2018	1,551	2,164	$178,246
2019	1,439	2,307	$177,352
2020	999	1,675	$132,435
2021	1,320	2,227	$168,558
2022	1,374	2,228	$175,385
2023	1,536	2,303	$171,096
2024	1,617	2,318	$190,890

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Year	Patients	Claims	Drug Cost
2015	210	2,176	$92,588
2016	216	2,143	$87,436
2017	226	2,082	$100,561
2018	239	2,401	$142,692
2019	251	2,222	$172,637
2020	234	2,399	$474,348
2021	250	2,477	$516,468
2022	248	2,398	$704,669
2023	238	2,290	$982,573
2024	246	2,256	$1,657,911

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

No connected DME records

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

Code	Description	Patients	Clm Lines	Total Payment
93351	Ultrasound of heart with continuous electrocardiogram (ecg) during rest, exercise and/or drug induced stress with review and report	156	158	$216
93306	Ultrasound of heart with color-depicted blood flow, rate, direction and valve function	448	455	$190
99214	Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more	184	346	$113
93000	Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report	231	238	$13
93010	Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report only	632	903	$7

Top 5 Part D drugs in 2024

By total drug costs.

Drug	Generic	Claims	Total Day Supply	Total Drug Cost
Vyndamax	Tafamidis	36	1,080	$807,764
Vyndaqel	Tafamidis Meglumine	13	630	$469,142
Eliquis	Apixaban	113	7,380	$140,999
Entresto	Sacubitril/Valsartan	125	5,460	$119,391
Farxiga	Dapagliflozin Propanediol	32	1,920	$34,351

Top 5 DME services in 2024

No connected or detailed DME service-level records for 2024.

Open Payments Summary in 2024

Category	Definition	Records	Total Reported Amount	Top Related Entity
General Payments	Reported payment or transfer-of-value amount.	1	$129	Impulse Dynamics (USA) Inc.
Research Payments	Reported research-related payment or transfer-of-value amount.	0	$0	N/R
Ownership / Investment Interests	Reported value of ownership or investment interests.	0	$0	N/R

Explore More Providers

FAQ

What Medicare data is available for Aria Dibiase, MD?

Tedicare shows public-source Medicare data for Aria Dibiase, MD (NPI 1033273727), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Aria Dibiase, MD have ACO affiliation data?

Aria Dibiase, MD is shown with ACO affiliation data for Sutter Medicare Direct (MSSP, ACO ID A5279).

What billing organization is linked to Aria Dibiase, MD?

Aria Dibiase, MD is linked to SUTTER BAY MEDICAL FOUNDATION (billing NPI 1013950807) in the available physician profile data.

Does Aria Dibiase, MD have Open Payments data?

Aria Dibiase, MD has 1 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.